Cargando…

DMTO: a realistic ontology for standard diabetes mellitus treatment

BACKGROUND: Treatment of type 2 diabetes mellitus (T2DM) is a complex problem. A clinical decision support system (CDSS) based on massive and distributed electronic health record data can facilitate the automation of this process and enhance its accuracy. The most important component of any CDSS is...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sappagh, Shaker, Kwak, Daehan, Ali, Farman, Kwak, Kyung-Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800094/
https://www.ncbi.nlm.nih.gov/pubmed/29409535
http://dx.doi.org/10.1186/s13326-018-0176-y
_version_ 1783298139074068480
author El-Sappagh, Shaker
Kwak, Daehan
Ali, Farman
Kwak, Kyung-Sup
author_facet El-Sappagh, Shaker
Kwak, Daehan
Ali, Farman
Kwak, Kyung-Sup
author_sort El-Sappagh, Shaker
collection PubMed
description BACKGROUND: Treatment of type 2 diabetes mellitus (T2DM) is a complex problem. A clinical decision support system (CDSS) based on massive and distributed electronic health record data can facilitate the automation of this process and enhance its accuracy. The most important component of any CDSS is its knowledge base. This knowledge base can be formulated using ontologies. The formal description logic of ontology supports the inference of hidden knowledge. Building a complete, coherent, consistent, interoperable, and sharable ontology is a challenge. RESULTS: This paper introduces the first version of the newly constructed Diabetes Mellitus Treatment Ontology (DMTO) as a basis for shared-semantics, domain-specific, standard, machine-readable, and interoperable knowledge relevant to T2DM treatment. It is a comprehensive ontology and provides the highest coverage and the most complete picture of coded knowledge about T2DM patients’ current conditions, previous profiles, and T2DM-related aspects, including complications, symptoms, lab tests, interactions, treatment plan (TP) frameworks, and glucose-related diseases and medications. It adheres to the design principles recommended by the Open Biomedical Ontologies Foundry and is based on ontological realism that follows the principles of the Basic Formal Ontology and the Ontology for General Medical Science. DMTO is implemented under Protégé 5.0 in Web Ontology Language (OWL) 2 format and is publicly available through the National Center for Biomedical Ontology’s BioPortal at http://bioportal.bioontology.org/ontologies/DMTO. The current version of DMTO includes more than 10,700 classes, 277 relations, 39,425 annotations, 214 semantic rules, and 62,974 axioms. We provide proof of concept for this approach to modeling TPs. CONCLUSION: The ontology is able to collect and analyze most features of T2DM as well as customize chronic TPs with the most appropriate drugs, foods, and physical exercises. DMTO is ready to be used as a knowledge base for semantically intelligent and distributed CDSS systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13326-018-0176-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5800094
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58000942018-02-13 DMTO: a realistic ontology for standard diabetes mellitus treatment El-Sappagh, Shaker Kwak, Daehan Ali, Farman Kwak, Kyung-Sup J Biomed Semantics Research BACKGROUND: Treatment of type 2 diabetes mellitus (T2DM) is a complex problem. A clinical decision support system (CDSS) based on massive and distributed electronic health record data can facilitate the automation of this process and enhance its accuracy. The most important component of any CDSS is its knowledge base. This knowledge base can be formulated using ontologies. The formal description logic of ontology supports the inference of hidden knowledge. Building a complete, coherent, consistent, interoperable, and sharable ontology is a challenge. RESULTS: This paper introduces the first version of the newly constructed Diabetes Mellitus Treatment Ontology (DMTO) as a basis for shared-semantics, domain-specific, standard, machine-readable, and interoperable knowledge relevant to T2DM treatment. It is a comprehensive ontology and provides the highest coverage and the most complete picture of coded knowledge about T2DM patients’ current conditions, previous profiles, and T2DM-related aspects, including complications, symptoms, lab tests, interactions, treatment plan (TP) frameworks, and glucose-related diseases and medications. It adheres to the design principles recommended by the Open Biomedical Ontologies Foundry and is based on ontological realism that follows the principles of the Basic Formal Ontology and the Ontology for General Medical Science. DMTO is implemented under Protégé 5.0 in Web Ontology Language (OWL) 2 format and is publicly available through the National Center for Biomedical Ontology’s BioPortal at http://bioportal.bioontology.org/ontologies/DMTO. The current version of DMTO includes more than 10,700 classes, 277 relations, 39,425 annotations, 214 semantic rules, and 62,974 axioms. We provide proof of concept for this approach to modeling TPs. CONCLUSION: The ontology is able to collect and analyze most features of T2DM as well as customize chronic TPs with the most appropriate drugs, foods, and physical exercises. DMTO is ready to be used as a knowledge base for semantically intelligent and distributed CDSS systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13326-018-0176-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-06 /pmc/articles/PMC5800094/ /pubmed/29409535 http://dx.doi.org/10.1186/s13326-018-0176-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
El-Sappagh, Shaker
Kwak, Daehan
Ali, Farman
Kwak, Kyung-Sup
DMTO: a realistic ontology for standard diabetes mellitus treatment
title DMTO: a realistic ontology for standard diabetes mellitus treatment
title_full DMTO: a realistic ontology for standard diabetes mellitus treatment
title_fullStr DMTO: a realistic ontology for standard diabetes mellitus treatment
title_full_unstemmed DMTO: a realistic ontology for standard diabetes mellitus treatment
title_short DMTO: a realistic ontology for standard diabetes mellitus treatment
title_sort dmto: a realistic ontology for standard diabetes mellitus treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800094/
https://www.ncbi.nlm.nih.gov/pubmed/29409535
http://dx.doi.org/10.1186/s13326-018-0176-y
work_keys_str_mv AT elsappaghshaker dmtoarealisticontologyforstandarddiabetesmellitustreatment
AT kwakdaehan dmtoarealisticontologyforstandarddiabetesmellitustreatment
AT alifarman dmtoarealisticontologyforstandarddiabetesmellitustreatment
AT kwakkyungsup dmtoarealisticontologyforstandarddiabetesmellitustreatment